Pure Global
NCT04456491

The Clinical Value of the Nitric Oxide System Components in Asthma and COPD

The Clinical Value of the Nitric Oxide System Components in Asthma and Chronic Obstructive Pulmonary Disease
Ryazan State Medical University·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Asthma,COPD
Study type
Observational
Sponsor & location
Primary sponsor
Ryazan State Medical University
Location
Ryazan', Russian Federation
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2021
End date
Jun 30, 2025
Enrollment
240 participants
Primary outcome

Combined outcome - clinical worsening

Summary

It is planned to conduct a study of nitric oxide metabolites (nitrates and nitrites),
 L-arginine, arginase-1, and asymmetric dimethylarginine in patients with bronchial asthma and
 chronic obstructive pulmonary disease, followed by observation to assess the prognosis of the
 disease.

ICD-10 classifications
AsthmaAsthma, unspecifiedNonallergic asthmaMixed asthmaOther chronic obstructive pulmonary disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04456491
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04456491 through Pure Global AI's free database. This phase not specified trial is sponsored by Ryazan State Medical University and is currently Recruiting. The study focuses on Asthma,COPD. Target enrollment is 240 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.